The GENEGUT project benefits from a collaborative network of distinguished scientists, many of whom have recently been included in Stanford University’s Top 2% Scientists list, recognising significant research contributions based on citation impact.
The researchers
From University College Cork:
- Professor Caitriona O’Driscoll – GENEGUT Project Coordinator, Chair of Pharmaceutics, School of Pharmacy, specialising in RNA drug delivery systems.
- Professor Brendan Griffin – Professor in Biopharmaceutics & Drug Delivery and Head of the School of Pharmacy.
- Dr Piotr Kowalski – Senior Lecturer in Advanced Therapies and Funded Investigator at APC Microbiome Ireland.
- Professor Subrata Ghosh – Chair and Head of Medicine at UCC, specialising in precision medicine for IBD.
From Bangor University:
- Professor Dyfrig Hughes – Co-director of the Centre for Health Economics and Medicines Evaluation, with expertise in pharmaceutical economics.
Prof. Caitriona O'Driscoll
Project Coordinator
Prof. Brendan Griffin
Dr. Piotr Kowalski
Prof. Subrata Ghosh
Prof. Dyfrig Hughes
Prof. Per Artursson
Prof. Bruno Sarmento
Dr. Vincent Jannin
From Uppsala University:
- Professor Per Artursson – Professor of Dosage Form Design and Head of the Drug Delivery research team, focusing on optimising drug absorption.
From i3S:
- Professor Bruno Sarmento – leads the Nanomedicines & Translational Drug Delivery group, with research in advanced nanomedicine and preclinical models.
From Lonza:
- Dr Vincent Jannin – Director of Research&Development and Head of Innovaform™ Accelerator, with expertise in capsule applications and pharmaceutical excipients.
Research excellence
Their inclusion in the Stanford list reflects both individual excellence and each partner’s commitment to innovation in healthcare sciences, underscoring the strength of GENEGUT’s collaborative approach to advancing gut health research. We are delighted to have them on the GENEGUT team and congratulate them on their achievements!